HIV-1 DNA persists in infected cells despite combined antiretroviral therapy (cART), forming
viral reservoirs. Recent trials of strategies targeting latent HIV reservoirs have rekindled …

The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India 1 , 2 , 3 , 4 – 5 .
Since then, it has become dominant in some regions of India and in the UK, and has spread to …

… Van Geet and L. Sels for their support; … Legros and L. Courtellemont for their help with the
cohorts. The Opera system was co-funded by Institut Pasteur and the Région ile de France (…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …

The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …

Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities
but cannot cure the infection. Given the difficulty of eradicating HIV-1, a functional cure for …

Background Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was
recently approved in the United States for the treatment of human immunodeficiency virus …

Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …

Background. The pilot phase IIb VIKING study suggested that dolutegravir (DTG), a human
immunodeficiency virus (HIV) integrase inhibitor (INI), would be efficacious in INI-resistant …

OBJECTIVE: To describe the main features of bone infection associated with Cat-scratch
disease (CSD). METHODS: We searched for articles indexed in the international literature …